Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention

Pharmaceutical Research - United States
doi 10.1007/s11095-010-0051-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PLK1 (Polo-Like Kinase 1 (Drosophila))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Regulating a Key Mitotic Regulator, Polo-Like Kinase 1 (PLK1)

Cytoskeleton
Cell BiologyStructural Biology
2018English

Bioorthogonal Probes for Polo-Like Kinase 1 Imaging and Quantification

Angewandte Chemie
2011English

Polo-Like-Kinase 1: A Key Cellular Target for Anti-HBV Therapy?

Hepatology
MedicineHepatology
2017English

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas

Frontiers in Oncology
Cancer ResearchOncology
2019English

ELISA-based Polo-Like Kinase 1 (PLK1; STPK13) Assay

Science-Business eXchange
2009English

Upregulated Polo-Like Kinase 1 Expression Correlates With Inferior Survival Outcomes in Rectal Cancer

PLoS ONE
Multidisciplinary
2015English

Polo-Like Kinase-1 as a Novel Target in Neoplastic Mast Cells: Demonstration of Growth-Inhibitory Effects of Small Interfering RNA and the Polo-Like Kinase-1 Targeting Drug BI 2536

Haematologica
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy